Abstract
Background
A vestibular schwannoma (VS) is a benign nerve sheath tumor derived from the vestibular nerves. The growth rate of VS during long-term follow-up has not yet been fully evaluated. We aimed to investigate the growth rate of newly diagnosed VS and the related predictive factors for tumor growth.
Methods
A retrospective review was performed using VS patients who underwent at least two magnetic resonance imaging (MRI) scans before tumor growth was observed. Tumor growth was defined as a size increase of more than 2 mm in the longest diameter of the tumor. To assess the growth rate of VS and related factors, we assessed tumor growth using survival analysis. Survival analysis to assess the growth rate and Cox regression analysis were performed to find related factors.
Results
The study included 118 patients. The mean age of patients was 57.0 ± 12.9 years. During the observation period, the 5-year cumulative growth incidence rate was 41.3% by survival analysis. Extrameatal tumor location and hearing loss were found to be associated with an increased hazard ratio (HR) for tumor growth.
Conclusion
After long-term observation of VS, 41.3% of VS patients presented cumulative growth incidence rate in the first 5 years after diagnosis. Extrameatal tumor location and hearing changes were related to subsequent tumor growth.
Similar content being viewed by others
References
American Academy of Otolaryngology-Head and Neck Surgery Foundation (1995) Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation. INC Otolaryngol Head Neck Surg 113:179–180
Anand VT, Kerr AG, Byrnes DP, Smyth GD (1992) Non-surgical management of acoustic neuromas. Clin Otolaryngol Allied Sci 17:406–410
Artz JC, Timmer FC, Mulder JJ, Cremers CW, Graamans K (2009) Predictors of future growth of sporadic vestibular schwannomas obtained by history and radiologic assessment of the tumor. Eur Arch Otorhinolaryngol 266:641–646
Bakkouri WE, Kania RE, Guichard JP, Lot G, Herman P, Huy PT (2009) Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg 110:662–669
Battaglia A, Mastrodimos B, Cueva R (2006) Comparison of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol 27:705–712
Borsetto D, Gair J, Kenyon O, Das T, Donnelly N, Axon P, Macfarlane R, Mannion R, Scoffings D, Bance M, Tysome J (2019) When should we stop scanning older patients with vestibular schwannomas? J Neurol Surg B Skull Base 80:333–337
Carlson ML, Tveiten OV, Driscoll CL, Goplen FK, Neff BA, Pollock BE, Tombers NM, Castner ML, Finnkirk MK, Myrseth E, Pedersen PH, Lund-Johansen M, Link MJ (2015) Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg 122:833–842
Charabi S, Tos M, Thomsen JC, Charabi BW, Mantoni MY (2000) Vestibular schwannoma. A new interpretation of tumor growth. Ugeskr Laeger 162:5497–5500
Ferri GG, Modugno GC, Pirodda A, Fioravanti A, Calbucci F, Ceroni AR (2008) Conservative management of vestibular schwannomas: an effective strategy. Laryngoscope 118:951–957
Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D, Evans DG, Lefranc F, Sallabanda K, Falini A, Axon P, Sterkers O, Fariselli L, Wick W, Tonn JC (2020) EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol 22:31–45
Hunter JB, Francis DO, O’Connell BP, Kabagambe EK, Bennett ML, Wanna GB, Rivas A, Thompson RC, Haynes DS (2016) Single institutional experience with observing 564 vestibular schwannomas: factors associated with tumor growth. Otol Neurotol 37:1630–1636
Jethanamest D, Rivera AM, Ji H, Chokkalingam V, Telischi FF, Angeli SI (2015) Conservative management of vestibular schwannoma: predictors of growth and hearing. Laryngoscope 125:2163–2168
Jongkees LB, Maas JP, Philipszoon AJ (1962) Clinical nystagmography. A detailed study of electro-nystagmography in 341 patients with vertigo. Pract Otorhinolaryngol (Basel) 24:65–93
Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI (2003) New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol 24:642–648 (discussion 648-649)
Kurland LT (1958) The frequency of intracranial and intraspinal neoplasms in the resident population of Rochester, Minnesota. J Neurosurg 15:627–641
Lee JD, Park MK, Kim JS, Cho YS (2014) The factors associated with tumor stability observed with conservative management of intracanalicular vestibular schwannoma. Otol Neurotol 35:918–921
Macielak RJ, Patel NS, Lees KA, Lohse CM, Marinelli JP, Link MJ, Carlson ML (2019) Delayed tumor growth in vestibular schwannoma: an argument for lifelong surveillance. Otol Neurotol 40:1224–1229
Massick DD, Welling DB, Dodson EE, Scholfield M, Nagaraja HN, Schmalbrock P, Chakeres DW (2000) Tumor growth and audiometric change in vestibular schwannomas managed conservatively. Laryngoscope 110:1843–1849
Moffat DA, Kasbekar A, Axon PR, Lloyd SK (2012) Growth characteristics of vestibular schwannomas. Otol Neurotol 33:1053–1058
Myrseth E, Pedersen PH, Moller P, Lund-Johansen M (2007) Treatment of vestibular schwannomas. Why, when and how? Acta Neurochir (Wien) 149:647–660 (discussion 660)
Ogawa K, Kanzaki J, Ogawa S, Yamamoto M, Ikeda S, Shiobara R (1991) The growth rate of acoustic neuromas. Acta Otolaryngol Suppl 487:157–163
Roehm PC, Gantz BJ (2007) Management of acoustic neuromas in patients 65 years or older. Otol Neurotol 28:708–714
Sakamoto T, Fukuda S, Inuyama Y (2001) Hearing loss and growth rate of acoustic neuromas in follow-up observation policy. Auris Nasus Larynx 28(Suppl):S23-27
Sethi M, Borsetto D, Cho Y, Gair J, Gamazo N, Jefferies S, Joannides A, Mannion R, Helmy A, Axon P, Donnelly N, Tysome JR, Bance M (2020) The conditional probability of vestibular schwannoma growth at different time points after initial stability on an observational protocol. Otol Neurotol 41:250–257
Smouha EE, Yoo M, Mohr K, Davis RP (2005) Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope 115:450–454
Solares CA, Panizza B (2008) Vestibular schwannoma: an understanding of growth should influence management decisions. Otol Neurotol 29:829–834
Stangerup SE, Caye-Thomasen P (2012) Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am 45(vii):257–268
Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J (2006) The natural history of vestibular schwannoma. Otol Neurotol 27:547–552
Strasnick B, Glasscock ME 3rd, Haynes D, McMenomey SO, Minor LB (1994) The natural history of untreated acoustic neuromas. Laryngoscope 104:1115–1119
Suryanarayanan R, Ramsden RT, Saeed SR, Aggarwal R, King AT, Rutherford SA, Evans DG, Gillespie JE (2010) Vestibular schwannoma: role of conservative management. J Laryngol Otol 124:251–257
Tanaka Y, Hongo K, Tada T, Kobayashi S (2003) What is the best method for reporting tumor diameter in vestibular schwannoma? Neurosurgery 53:634–637 (discussion 637-638)
Tos M, Charabi S, Thomsen J (1999) Incidence of vestibular schwannomas. Laryngoscope 109:736–740
Tos M, Stangerup SE, Caye-Thomasen P, Tos T, Thomsen J (2004) What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg 130:216–220
Tschudi DC, Linder TE, Fisch U (2000) Conservative management of unilateral acoustic neuromas. Am J Otol 21:722–728
Wiet RJ, Zappia JJ, Hecht CS, O’Connor CA (1995) Conservative management of patients with small acoustic tumors. Laryngoscope 105:795–800
Yoshimoto Y (2005) Systematic review of the natural history of vestibular schwannoma. J Neurosurg 103:59–63
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of Samsung Medical Center (No. 2020–07-097) and with the 1964 Helsinki declaration and its later amendments or comparable standards.
Informed consent
The requirement for informed consent was waived by the Institutional Review Board of Samsung Medical Center.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Brain Tumors
Rights and permissions
About this article
Cite this article
Kim, J.S., Cho, YS. Growth of vestibular schwannoma: long-term follow-up study using survival analysis. Acta Neurochir 163, 2237–2245 (2021). https://doi.org/10.1007/s00701-021-04870-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-021-04870-8